Shaping alternative NF-κB-dependent gene expression programs: New clues to specificity

Cell Death and Differentiation

Volumn 13, Issue 5, 2006, Pages 693-696

  Natoli, Gioacchino ^a   De Santa, F ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCOCORTICOID RECEPTOR; I KAPPA B ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 12P40; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN P52; RANTES; STAT1 PROTEIN; STAT2 PROTEIN; SYNAPTOTAGMIN; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; TUMOR NECROSIS FACTOR ALPHA;

BINDING AFFINITY; BINDING SITE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CYTOKINE RELEASE; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; INNATE IMMUNITY; NONHUMAN; NOTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CONFORMATION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; CHROMATIN; GENE EXPRESSION REGULATION; HUMANS; MODELS, BIOLOGICAL; NF-KAPPA B; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 33646005534     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401880     Document Type: Note

References (34)

1. Hoffmann A et al. (2002) Science 298: 1241-1245.
2. Beg AA et al. (1995) Genes Dev. 9: 2736-2746.
3. Covert MW et al. (2005) Science 309: 1854-1857.
4. Werner SL, Barken D, Hoffmann A (2005) Science 309: 1857-1861.
5. Kawai T et al. (2001) J. Immunol 167: 5887-5894.
6. Saccani S, Pantano S, Natoli G (2002) Nat. Immunol. 3: 69-75.
7. Bonizzi G et al. (2004) EMBO J. 23: 4202-4210.
8. Udalova IA et al. (2002) Proc. Natl. Acad. Sci. USA 99: 8167-8172.
9. Natoli G et al. (2005) Nat. Immunol. 6: 439-445.
10. Hoffmann A, Leung TH, Baltimore D (2003) EMBO J. 22: 5530-5539.
11. Saccani S, Pantano S, Natoli G (2003) Mol. Cell 11: 1563-1574.
12. Attar RM et al. (1997) Semin. Cancer Biol. 8: 93-101.
13. Sanjabi S et al. (2005) Genes Dev. 19: 2138-2151.
14. Kontgen F et al. (1995) Genes Dev. 9: 1965-1977.
15. Gerondakis S et al. (1996) Proc. Natl. Acad. Sci. USA 93: 3405-3409.
16. Sanjabi S et al. (2000) Proc. Natl. Acad. Sci. USA 97: 12705-12710.
17. Huxford T, Malek S, Ghosh G (1999) Cold Spring Harb. Symp. Quart. Biol. 64: 533-540.
18. Grumont R et al. (2001) J. Exp. Med. 194: 1021-1032.
19. Ouaaz F et al. (2002) Immunity 16: 257-270.
20. Taniguchi T et al. (2001) Annu. Rev. Immunol. 19: 623-655.
21. Sharma S et al. (2003) Science 300: 1148-1151.
22. Fitzgerald KA et al. (2003) Nat. Immunol. 4: 491-496.
23. Toshchakov V et al. (2002) Nat. Immunol. 3: 392-398.
24. Doyle S et al. (2002) Immunity 17: 251-263.
25. De Bosscher K, Vanden Berghe W, Haegeman G (2003) Endocr. Rev. 24: 488-522.
26. Ogawa S et al. (2005) Cell 122: 707-721.
27. Wietek C et al. (2003) J. Biol. Chem. 278: 50923-50931.
28. Park JM et al. (2002) Science 297: 2048-2051.
29. Park JM et al. (2005) Immunity 23: 319-329.
30. Senger K et al. (2004) Mol. Cell 13: 19-32.
31. Saccani S, Pantano S, Natoli G (2001) J. Exp. Med. 193: 1351-1359.
32. Bernstein BE et al. (2004) Genome Biol. 5: R62.
33. Angelov D et al. (2004) J. Biol. Chem. 279: 42374-42382.
34. Angelov D et al. (2003) Mol. Cell 11: 1033-1041.